Navigation Links
Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Date:5/9/2008

tain nature of the forward-looking statements include: risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, and costs associated with internal development and business development activities. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.


'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... Conference, to be held March 8-11, 2015, in ... James Sapirstein , Chief Executive Officer, will provide an ... and will be available to participate in one-on-one meetings ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... nation,s top rehabilitation hospitals for spinal cord injury and ... clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... cord injury (SCI). The Phase 1/2a ...
(Date:3/5/2015)... and VANCOUVER, British Columbia ... BUX FSE: 20B OTCQB: BMKDF) -- The ultimate goal ... assay that is capable of detecting tumors before they ... years, the development of such an assay has been ... academia and industry. Although many breakthrough diagnostics have been ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... DANBURY, Conn., March 8, 2012  Biodel Inc. (Nasdaq: ... Souza, President and CEO of Biodel, will present a ... Conference on ­­­­­­­­­March 14, 2012 at 3:00 p.m. Pacific ... ROTH 24th Annual OC Growth Stock Conference will be ...
... Germany, March 8, 2012   , ...   QIAGEN,s   digene ... testing for high-risk types of human papillomavirus (HPV), the primary cause ... Day, QIAGEN also joins fifth year of campaign to provide free ...
Cached Medicine Technology:QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics 2QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics 3QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics 4
(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... 05, 2015 On March 2, 2015, ... Labiaplasty on the Rise, Plastic Surgeons Say,” that comments ... Society for Aesthetic Plastic Surgery and the ... reported a year-over-year doubling of surgical butt augmentations performed ... in the article, this increase can be attributed to ...
(Date:3/5/2015)... At the 7th Annual Mississippi ... addiction treatment met today in Jackson, Mississippi to listen ... Among the numerous respected speakers will be William ... role that pain medications have had in today’s opiate ... , "It is hard to believe that much of ...
(Date:3/5/2015)... 2015 University of Western States ... 1904, has launched a new center of excellence ... The Northwest Center for Lifestyle and Functional Medicine ... outreach, and conduct research in the areas of ... nutrition. The center will target efforts on the ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... NY orthopedic Surgeon ( http://www.orthopedicsurgeonnyc.com ) has been named ... in the New York Metro area. Dr. Glashow has ... in its authoritative guide to the top specialty care ... 2015. , The prestigious Castle Connolly program, which carefully ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2
... 30 (HealthDay News) -- Winter does have its pluses for ... to get hay fever. But folks tend to spend ... trigger other allergy and asthma problems, experts warn. The ... for keeping yourself sniffle-free if you,re cooped up inside: ...
... News) -- Researchers report that they,ve gained insight into the ... role in how the body stores fat to protect against ... to be linked to both insulin sensitivity and the survival ... between all these different phenomena," Dr. Philipp Scherer, a professor ...
... Gardner HealthDay Reporter , WEDNESDAY, Dec. 29 ... experienced nurse improved the health of patients suffering from ... depression. A study appearing in the Dec. 30 ... reports improvements in the four areas of blood ...
... a new chance at life. But many who receive one ... build up in the lungs and chokes off the ability ... diagnostic tool they developed to predict bronchiolitis obliterans syndrome (BOS) ... life-saving treatments. BOS is the leading cause of death ...
... , WEDNESDAY, Dec. 29 (HealthDay News) -- Federal researchers ... risks facing people with a rare immune system-weakening condition ... personalized treatment. "Advances in treatment of CGD ... disease of early childhood to survive into adulthood; however, ...
... Dec. 29 (HealthDay News) -- Stretching before taking warm-up ... suggests. Doing a passive, static stretching routine before ... speed, distance, accuracy and consistent ball contact," according to ... in Nacogdoches, Texas. He compared two different warm-up ...
Cached Medicine News:Health News:Take Steps to Avoid Winter's Indoor Allergies 2Health News:Research Sheds Light on 'Starvation Hormone' 2Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 2Health News:Team-Based Treatment Helps Those With Cluster of Chronic Illnesses 3Health News:New test announced for major killer of lung transplant patients 2Health News:U.S. Researchers Find New Way to Gauge Rare Genetic Condition 2Health News:Stretching Before Warm-Up Swings May Harm Golf Game 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: